New survival data for pembrolizumab plus axitinib in advanced kidney cancer
A paper published in The Lancet Oncology this month provides [...]
A paper published in The Lancet Oncology this month provides [...]
In this phase 1b/2 study the researchers looked at a [...]
The Sottish Medicine Consortium (SMC) have issued a final decision to recommend [...]
Cabozantinib and sunitinib are both drugs that block the development [...]
The discovery of a reliable biomarker for how patients with [...]
These two videos with Dr Eric Jonasch from MD Anderson [...]
A recent study coming out of China has identified a [...]
Brain metastases in patients with renal cell carcinoma (RCC) is [...]
An educational symposium was held from 8-10 August as part [...]
An educational symposium was held from 8-10 August as part [...]